Dec 19, 2017 - Array Biopharma Inc (ARRY) CEO Ron Squarer Sold $8.9 million of Shares, Stocks: ARRY, release date:Dec 19, 2017
Dec 19, 2017 -
Despite a 15-percent decline throughout 2017, ARRIS International plc (NASDAQ: ARRS) was still favorably viewed by some on the Street, but on Tuesday a notable analyst changed their previously bullish thesis.
Dec 19, 2017 - While performance for December continues to disappoint, we continue to position the ROTY model account for a profitable 2018.Argenx received a very large price hike from an analyst.Global Blood Therap
Dec 14, 2017 - Arris (NASDAQ:ARRS) fell 6.3% today and touched its lowest point since early September after holding a call where it said it expects margin pressures from memory pricing to stretch some distance into
Dec 11, 2017 - Investors need to pay close attention to Array BioPharma (ARRY) stock based on the movements in the options market lately.
Dec 02, 2017 - Shares have risen a decent bit since my initial entries, but I believe 2018 holds substantially more upside ahead.Below I provide a recap of the bullish thesis and recent events.After its September se
Nov 21, 2017 - Investors need to pay close attention to Array BioPharma (ARRY) stock based on the movements in the options market lately.
Nov 07, 2017 - Steven Cohen Takes Stake in Karyopharm Therapeutics, Stocks: KPTI,ADMS,ONCS,GBT,ARRY,PCRX,AKAO, Steven Cohen, release date:Nov 07, 2017
Oct 04, 2017 - Steven Cohen Doubles Down on Sickle Cell Disease Therapeutics Company Global Blood, Stocks: GBT,ARRY,PCRX,AKAO, Steven Cohen, release date:Oct 04, 2017
Oct 03, 2017 - Ono is reaping the benefits of Opdivo's growth, but there is ample competition in the PD-1 space, and growth will be tied to clinical success, competitors' results, and government pricing.Ono's intern